Fentanyl decreases blood oxygen more than furanylfentanyl despite similar effects on breathing

Rationale: Fatal opioid overdoses involving synthetic opioids have increased >10-fold over the past 8 years. Fentanyl, a potent synthetic opioid acting at the mu-opioid receptor (MOR), has largely replaced heroin as the predominant illicit opioid available. Various analogs have been synthesized from the fentanyl scaffold, including 2-furanylfentanyl, one of the most trafficked analogs from 2019 to 2024. Despite its prevalence, the in vivo effects of furanylfentanyl are not well characterized, especially regarding respiratory depression. Objectives: To characterize furanylfentanyl relative to fentanyl in vitro and compare the effects of both drugs in mouse models of antinociception and respiratory depression. Methods: The affinity and potency of fentanyl and furanylfentanyl were determined in CHO cells overexpressing MOR. Male and female mice were administered (i.p.) fentanyl or furanylfentanyl prior to measuring antinociception (warm-water tail withdrawal), respiration (whole-body plethysmography), or oxygen saturation (pulse oximetry). Results: Furanylfentanyl behaves as a partial agonist in vitro relative to fentanyl and morphine but with similar affinity and potency at MOR. In mice, fentanyl and furanylfentanyl produced similar effects on breathing parameters (including rate and inspiration time) that were greater than those induced by morphine, yet only fentanyl caused a drastic, long-lasting depletion of blood oxygen saturation. The discrepancy between effects on breathing and oxygen saturation may be explained by a greater number of apneas induced by fentanyl. Conclusions: These results highlight the complexity of fentanyl-induced respiratory depression and indicate that recreational use of 2-furanylfentanyl in humans may pose a greater risk of overdose than morphine but lesser than fentanyl.

• Publication year

  2026

• Venue

  Research Square

• Publication date

  2026-01-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.21203/rs.3.rs-8398857/v1PMID 41646375PMCID 12869654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Peripheral opioid receptor antagonism alleviates fentanyl-induced cardiorespiratory depression and is devoid of aversive behavior

  2025cited by this paper
• In Vitro and In Vivo Pharmacological Characterization of Fentanyl Analogs.

  2025cited by this paper
• Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption.

  2025cited by this paper
• Assessment of abuse potential of furanylfentanyl and tetrahydrofuranylfentanyl

  2025cited by this paper
• Structure-Activity Relationships of the Fentanyl Scaffold: Identification of Antagonists as Potential Opioid Overdose Reversal Agents.

  2024cited by this paper
• Comparison of the effects of fentanyls and other μ opioid receptor agonists on the electrical activity of respiratory muscles in the rat

  2023cited by this paper
• Heroin- and Fentanyl-Induced Respiratory Depression in a Rat Plethysmography Model: Potency, Tolerance, and Sex Differences

  2023cited by this paper
• In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl.

  2022cited by this paper
• Understanding and countering opioid‐induced respiratory depression

  2021cited by this paper
• Receptor-Arrestin Interactions: The GPCR Perspective

  2021cited by this paper
• Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors.

  2020cited by this paper
• Notes from the Field: Opioid-Involved Overdose Deaths with Fentanyl or Fentanyl Analogs Detected — 28 States and the District of Columbia, July 2016–December 2018

  2020cited by this paper
• The correlation between oxygen saturation indices and the standard obstructive sleep apnea severity

  2020cited by this paper
• Fentanyl depression of respiration: comparison with heroin and morphine

  2019cited by this paper
• Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl

  2019cited by this paper
• Trends in fentanyl and fentanyl analogue-related overdose deaths - Montgomery County, Ohio, 2015-2017.

  2019cited by this paper
• Illicit fentanyls in the opioid street market: desired or imposed?

  2018cited by this paper
• Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.

  2018cited by this paper
• Curbing prescription opioid dependency

  2017cited by this paper
• Postmortem and Toxicological Findings in a Series of Furanylfentanyl-Related Deaths.

  2017cited by this paper
• Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project

  2016cited by this paper
• Mouse models of human disease

  2016cited by this paper
• Shifting Patterns of Prescription Opioid and Heroin Abuse in the United States.

  2015cited by this paper
• Sleep apnea monitoring and diagnosis based on pulse oximetery and tracheal sound signals

  2010cited by this paper
• Activities of mixed NOP and μ‐opioid receptor ligands

  2008cited by this paper
• Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.

  2006cited by this paper
• Of mice and men

  2005cited by this paper
• Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.

  1995cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• No citing papers are available for this paper.